The XFG variant of SARS-CoV-2, identified at the end of 2025 and still circulating in 2026, does not systematically cause the respiratory signs that the population has become accustomed to since the beginning of the pandemic. A recombinant lineage derived from two sub-variants of Omicron, XFG is characterized by subtle clinical presentations: simple fatigue, mild headaches, slight pain when swallowing. These minor forms, frequently observed in outpatient medicine, go unnoticed by both patients and healthcare providers.
One point deserves full attention: these atypical symptoms are not anecdotal. They directly contribute to diagnostic delays and distort the perception of the actual circulation of the virus in the population.
Neurocognitive symptoms of the Covid variant 2026: beyond ordinary fatigue
Among the least recognized manifestations of infections related to recent lineages, neurocognitive symptoms are increasingly prominent. An academic synthesis published by a team from the University of Liège on long Covid highlights sensory hypersensitivities, dysautonomia (dysregulation of the autonomic nervous system that controls heart rate, blood pressure, digestion), and post-exertional malaise without detectable abnormalities in standard examinations.
The problem is structural: these signs do not spontaneously suggest a respiratory infection. A patient who consults for postural dizziness or sudden noise intolerance will not be directed towards a Covid test. The link between a discreet respiratory infectious episode and these disorders is often invisible to the clinician.
To better understand the symptoms of the new Covid variant 2026, one must accept that the boundary between “post-infectious” and “active infectious” remains blurred in these neurocognitive forms. The virus may actively circulate in a person whose only complaint is persistent mental fog.
Digestive and cutaneous signs: rarely tested Covid symptoms
Digestive forms of Covid are not new to 2026, but their relative frequency increases when classic respiratory signs (dry cough, dyspnea) become rarer. Isolated nausea, brief diarrhea, moderate abdominal pain: these symptoms initially point towards seasonal gastroenteritis or food poisoning.
Cutaneous manifestations pose a similar problem. Fleeting rashes, localized redness, or itching without an obvious dermatological cause have been reported with recent variants. Their transient nature (from a few hours to two days) makes clinical documentation difficult.
- Isolated digestive disorders (without fever or cough) almost never trigger a screening test in general practice.
- Cutaneous manifestations often disappear before the consultation, preventing any correlation with a viral episode.
- The absence of associated respiratory signs reinforces the impression of a benign disorder unrelated to SARS-CoV-2.
The result is a massive detection bias: only patients presenting the “classic” picture (fever, cough, body aches) are tested, while digestive and cutaneous forms contribute to silent viral circulation.
Non-infectious geriatric forms: confusion, falls, dehydration
In elderly individuals, SARS-CoV-2 sometimes takes on a geriatric mask that has nothing to do with respiratory issues. Sudden confusion, unexplained falls, abrupt loss of appetite, or rapid dehydration may be the only signs of an active infection.
These presentations are known in geriatrics as “non-specific” infection symptoms. Covid did not invent this phenomenon, but it amplifies it: the normalization of the virus since the end of major waves has reduced the screening reflex in nursing homes.
A resident who falls twice in one week will first be evaluated for an orthopedic or neurological problem. The delay before a Covid test is considered can reach several days, during which transmission continues quietly in a vulnerable collective environment.
Why diagnostic delays are more serious in geriatrics
The window of efficacy for antivirals (such as nirmatrelvir/ritonavir) is narrow. A late diagnosis deprives fragile patients of early treatment that reduces the risk of severe forms. Meanwhile, the lack of rapid isolation fosters undetected clusters in care facilities.
Diagnostic delays and underestimation of viral circulation in France
The integrated surveillance set up by Santé publique France now monitors SARS-CoV-2 alongside influenza and bronchiolitis, within a common framework of acute respiratory infections. This grouping, epidemiologically relevant, has an indirect effect: Covid loses visibility when its clinical presentation does not resemble a respiratory infection.
Swiss virological surveillance confirms the phenomenon. During periods of low overall respiratory circulation, cases linked to recent lineages continue to be identified, but with such discreet presentations that they escape the traditional monitoring system. Fatigue alone, a mild headache, or a fleeting sore throat do not trigger consultations, tests, or reporting.
This situation creates a cycle: fewer tests lead to fewer detected cases, which reinforces the impression of low circulation, which further reduces the propensity to test.
- Antigen self-tests, less sensitive to low viral loads of subtle forms, miss a significant proportion of positive cases.
- Patients’ motivation to get tested decreases when symptoms do not match the “Covid” picture ingrained in the collective imagination (fever, anosmia, cough).
- City doctors, in the absence of systematic screening guidelines, logically reserve tests for evocative presentations.
A perception problem more than a virulence issue
The XFG variant is not classified as a variant of concern by the World Health Organization. Its clinical danger does not seem to exceed that of previous Omicron sub-lineages. The risk lies less in individual severity than in the collective underestimation of transmission, which allows the virus to circulate freely among at-risk populations.
The XFG’s ability to cause symptoms that no one spontaneously associates with Covid transforms each untested case into an invisible link in a transmission chain. As long as the diagnostic reflex remains conditioned by the classic respiratory picture, surveillance will underestimate the actual circulation of the virus, with direct consequences for the elderly, immunocompromised, or those with chronic conditions.